Challenges in the implementation of <scp>EAACI</scp> guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

Andreas Bonertz(Paul Ehrlich Institut), Stefan Vieths(Paul Ehrlich Institut), Roy Gerth van Wijk(Erasmus MC), Jennifer Bridgewater(United States Food and Drug Administration), Lars K. Poulsen(Gentofte Hospital), Elizabeth Angier(Northern General Hospital), Ruby Pawankar(Nippon Medical School), С. Бонини(University of Campania "Luigi Vanvitelli"), Aziz Sheikh(University of Oxford), Marcos Timón(Agencia Española de Medicamentos y Productos Sanitarios), Ronald L. Rabin(Center for Biologics Evaluation and Research), Ioana Agache(Transylvania University of Brașov), Susanne Halken(University of Southern Denmark), Óscar Palomares(Universidad Complutense de Madrid), Oliver Pfaar(Heidelberg University), Ronald van Ree(Amsterdam University Medical Centers), Montserrat Fernández‐Rivas(Hospital Clínico San Carlos), Ludger Klimek(Zentrum für Rhinologie und Allergologie), Gunter J. Sturm(Medical University of Graz), Domingo Barber(Universidad San Pablo CEU), Susanne Lau(Charité - Universitätsmedizin Berlin), Cezmi A. Akdiş(University of Zurich), Marek Jutel(Wroclaw Medical University), Giovanni Battista Pajno(University of Messina), Jorge Goldstein(Universidad de Buenos Aires), Graham Roberts(St Mary's Hospital), Thomas B. Casale(University of South Florida), Marcel H. N. Hoefnagel(Medicines Evaluation Board), Antonella Muraro(University of Padua), D. Hamerlijnk(Lung Foundation Netherlands), Claudio Rhyner(CK-CARE), C. Pini(Istituto Superiore di Sanità), E.‐M. Varga(Medical University of Graz), Jay E. Slater(United States Food and Drug Administration)
Allergy
August 3, 2017
Cited by 79


Related Papers